Lifeward Ltd. logo

Lifeward Ltd. (2RW)

Market Closed
12 Dec, 20:00
XMUN XMUN
4. 80
0
0%
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
4.8
Previous Close
Day Range
4.8 4.8
Year Range
4.8 4.8
Want to track 2RW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 68 days

Summary

2RW closed yesterday higher at €4.8, an increase of 0% from Thursday's close, completing a monthly increase of 0% or €0. Over the past 12 months, 2RW stock gained 0%.
2RW is not paying dividends to its shareholders.
The last earnings report, released on Nov 18, 2025, exceeded the consensus estimates by 0.01%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports. The next scheduled earnings report is due on Feb 19, 2026.
Lifeward Ltd. has completed 2 stock splits, with the recent split occurring on Mar 15, 2024.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

2RW Chart

Lifeward Ltd. (LFWD) Q3 2025 Earnings Call Transcript

Lifeward Ltd. (LFWD) Q3 2025 Earnings Call Transcript

Lifeward Ltd. ( LFWD ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Almog Adar - Chief Financial Officer William Grant - President, CEO & Director Conference Call Participants Yale Jen - Laidlaw & Company (UK) Ltd.

Seekingalpha | 4 weeks ago
Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript

Lifeward Ltd. (LFWD) Q2 2025 Earnings Call Transcript

Lifeward Ltd. (NASDAQ:LFWD ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Almog Adar - Chief Financial Officer William Mark Grant - President, CEO & Director Conference Call Participants Benjamin Charles Haynor - Lake Street Capital Markets, LLC, Research Division I-Eh Jen - Laidlaw & Company (UK) Ltd.

Seekingalpha | 4 months ago
Lifeward (LFWD) Reports Q2 Loss, Lags Revenue Estimates

Lifeward (LFWD) Reports Q2 Loss, Lags Revenue Estimates

Lifeward (LFWD) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.5 per share a year ago.

Zacks | 4 months ago

Lifeward Ltd. (2RW) FAQ

What is the stock price today?

The current price is €4.80.

On which exchange is it traded?

Lifeward Ltd. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is 2RW.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Feb 19, 2026.

Has Lifeward Ltd. ever had a stock split?

Lifeward Ltd. had 2 splits and the recent split was on Mar 15, 2024.

Lifeward Ltd. Profile

Health Care Technology Industry
Healthcare Sector
William Mark Grant CEO
XMUN Exchange
IL0011331076 ISIN
IL Country
80 Employees
- Last Dividend
15 Mar 2024 Last Split
- IPO Date

Overview

Lifeward Ltd. is a pioneering medical device company founded by Amit Goffer on June 20, 2001, with its headquarters based in Marlborough, MA. Specializing in the design, development, and marketing of wearable robotic exoskeletons, the company focuses on innovative solutions to enhance mobility for individuals suffering from spinal cord injuries (SCI). Lifeward Ltd.’s mission revolves around leveraging advanced technology to enable users to stand upright, walk, turn, and navigate stairs with ease, thereby improving their quality of life and fostering greater independence.

Products and Services

  • ReWalk Exo-Suit - This groundbreaking exoskeleton is designed to assist individuals who have experienced lower limb disabilities due to SCI. The ReWalk Exo-Suit stands out for its ability to support and stimulate hip and knee motion, enabling users to perform daily activities such as standing, walking, and turning with improved safety and mobility.
  • ReWalk Personal 6.0 - As an evolution of Lifeward Ltd.’s commitment to restorative mobility solutions, the ReWalk Personal 6.0 offers a more personalized and adaptive walking assistance for its users. Tailored to fit the unique needs of each individual, this version of the ReWalk exoskeleton allows users not only to stand and walk but also to climb and descend stairs, empowering them with even greater freedom in their movements.

Contact Information

Address: 3 Hatnufa Street
Phone: 972 4 959 0123